Sharon Shacham

USPTO Granted Patents = 50 (Patent Applications = 19)

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 15 (Patent Applications = 16)

Average Co-Inventor Count = 6.2

ph-index = 17

Forward Citations = 600(Granted Patents)

Forward Citations (Not Self Cited) = 299(Oct 12, 2025)

Location History:

Alfey Menashe, IL (2008 - 2011)
Chestnut Hill, MA (US) (2009 - 2016)
Newton, MA (US) (2009 - 2024)

Company Filing History:

29 out of 39

Karyopharm Therapeutics Inc.

Epix Pharmaceuticals, Inc.

patents

5. 2 out of 51

Microdose Therapeutx, Inc.

Nanotherapeutics, Inc.

9. 1 out of 832,680

Other

patents

Years Active: 2008-2025

Loading Chart...

50 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12331040 - Substituted benzofuranyl and benzoxazolyl compounds and uses thereof (2025-06-17),

2. 12291508 - Hydrazide containing nuclear transport modulators and uses thereof (2025-05-06),

3. 11945794 - Nuclear transport modulators and uses thereof (2024-04-02),

4. 11787771 - Hydrazide containing nuclear transport modulators and uses thereof (2023-10-17),

5. 11318120 - Nuclear transport modulators and uses thereof (2022-05-03),

6. 11124493 - Nuclear transport modulators and uses thereof (2021-09-21),

7. 11034660 - Hydrazide containing nuclear transport modulators and uses thereof (2021-06-15),

8. 11008309 - Substituted benzofuranyl and benzoxazolyl compounds and uses thereof (2021-05-18),

9. 10925859 - Nuclear transport modulators and uses thereof (2021-02-23),

10. 10722497 - Nuclear transport modulators and uses thereof (2020-07-28),

11. 10617677 - Nuclear transport modulators and uses thereof (2020-04-14),

12. 10544108 - Hydrazide containing nuclear transport modulators and uses thereof (2020-01-28),

13. 10407405 - Nuclear transport modulators and uses thereof (2019-09-10),

14. 10399963 - Substituted benzofuranyl and benzoxazolyl compounds and uses thereof (2019-09-03),

15. 10363247 - (S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer (2019-07-30),

Title: The Innovative Mind of Sharon Shacham

Introduction: Sharon Shacham is a pioneering inventor based in Newton, MA, known for her groundbreaking work in the field of biotechnology.

Latest Patents: Sharon Shacham holds several patents related to novel therapeutic approaches for the treatment of cancer and other diseases. Her most recent patent focuses on a new method for targeting specific cellular pathways involved in tumor growth.

Career Highlights: With a background in molecular biology and biochemistry, Sharon Shacham has dedicated her career to developing innovative therapies that target the underlying mechanisms of disease. She has received numerous awards for her contributions to the field of biotechnology.

Collaborations: Throughout her career, Sharon Shacham has collaborated with leading researchers, pharmaceutical companies, and academic institutions to further the development of her inventions. Her collaborative spirit has led to the successful translation of her research into clinical applications.

Conclusion: Sharon Shacham's relentless pursuit of innovation and her passion for improving patient outcomes have solidified her reputation as a trailblazer in the field of biotechnology. Her work continues to inspire the next generation of inventors and researchers in the quest for novel therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.